Role of neuropeptides in skin inflammation and its involvement in diabetic wound healing

Expert Opinion on Biological Therapy

Volumn 10, Issue 10, 2010, Pages 1427-1439

  Da Silva, Lucília ^a,b   Carvalho, Eugénia ^b   Cruz, Maria Teresa ^b,c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

diabetic foot ulcers; inflammation; neuropeptides; signaling pathways; skin cells; wound healing

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CORTICOTROPIN RELEASING FACTOR; INTERLEUKIN 10; NEUROPEPTIDE; SUBSTANCE P; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASOINTESTINAL POLYPEPTIDE;

CELL DIFFERENTIATION; CELL GROWTH; CELL MATURATION; CELL MIGRATION; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; DIABETIC FOOT; DIABETIC NEUROPATHY; HUMAN; KERATINOCYTE; LANGERHANS CELL; MACROPHAGE; MACROPHAGE ACTIVATION; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; WOUND HEALING;

ANIMALS; DIABETIC FOOT; DIABETIC NEUROPATHIES; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; NEUROPEPTIDES; SIGNAL TRANSDUCTION; SKIN; WOUND HEALING;

EID: 77956664657     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2010.515207     Document Type: Review

References (100)

1. Singer A, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-746
2. Cisarik-Fredenburg P. Discoveries in research on diabetic keratopathy. Optometry 2001;72:691-704
3. Galiano R. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol 2004;164:1935-1947
4. Goren I, Muller E, Pfeilschifter J, Frank S. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol 2006;168:765-777
5. Bogdanski P. Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus. Int J Clin Pharmacol Ther 2007;45:563-567
6. Lobmann R. Expression of matrix metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 2002;45:1011-1016
7. Loots M, Kenter SB, Au FL. Fibroblasts derived from chronic diabetic ulcers differ in their response to stimulation with EGF, IGFI, bFGF and PDGF-AB compared to controls. Eur J Cell Biol 2002;81:153-160
8. Stegenga M. Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans. Diabet Med 2008;25:157-164
9. Zykova S, Jenssen TG, Berdal M, et al. Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db/db mice. Diabetes 2000;49:1451-1458
10. Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen 2006;14:558-565
11. Roosterman D, Goerge T, Schneider SW, et al. Neuronal control of skin function: the skin as a neuroimmunoendocrine organ. Physiol Rev 2006;86:1309-1379
12. Bevan S, Hothi S, Hughes G, et al. Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 1992;107:544-552
13. Wollenberg A, Bieber T. Topical immunomodulatory agents and their targets in inflammatory skin diseases. Transplant Proc 2001;33:2212-2216
14. Maggi C. The pharmacology of the efferent function of sensory nerves. J Auton Pharmacol 1991;11:173-208
15. Rook J, Hasan W, McCarson KE. Morphine-induced early delays in wound closure: involvement of sensory neuropeptides and modification of neurokinin receptor expression. Biochem Pharmacol 2009;77:1747-1755
16. Antony A, Kong W, Lorenz HP. Upregulation of neurodevelopmental genes during scarless healing. Ann Plast Surg 2010;64:247-250
17. Scott J, Muangman P, Gibran NS. Making sense of hypertrophic scar: a role of nerves. Wound Repair Regen 2007;15:S27-31
18. Leung M, Wong CC. Expressions of putative neurotransmitters and neuronal growth related genes in Merkel cell-neurite complexes of the rats. Life Sci 2000;66:1481-1490
19. Wang H, Xing L, Li W, et al. Production and secretion of calcitonin gene-related peptide from human lymphocytes. J Neuroimmunol 2002;130:155-162
20. Olerud J, Usui ML, Seckin D, et al. Neutral endopeptidase expression and distribution in human skin and wounds. J Invest Dermatol 1999;112:873-881
21. Fitzpatrick T, Eisen AZ, Wolff K, et al. Dermatology in General Medicine. 5th edition. McGraw-Hill Books, New York; 1978;1:57-61
22. Peters E, Arck PC, Paus R. Hair growth inhibition by psychoemotional stress: a mouse model for neural mechanisms in hair growth control. Exp Dermatol 2006;15:1-13
23. Zhou Z, Kawana S, Aoki E, et al. Dynamic changes in nerve growth factor and substance P in the murine hair cycle induced by depilation. J Dermatol 2006;33:833-841
24. Seike M, Ikeda M, Morimoto A, et al. Increased synthesis of calcitonin gene-related peptide stimulates keratinocyte proliferation in murine UVB-irradiated skin. J Dermatol Sci 2002;28:135-143
25. Chakraborty A, Pawelek J. MSH receptors in immortalized human epidermal keratinocytes: a potential mechanism for coordinate regulation of the epidermal-melanin unit. J Cell Physiol 1993;157:344-350
26. Funasaka Y, Chakraborty AK, Yodoi J, Ichihashi M. The effect of thioredoxin on the expression of proopiomelanocortin-derived peptides, the melanocortin 1 receptor and cell survival of normal human keratinocytes. J Invest Dermatol 2001;6:32-37
27. Lee Y, Dlugosz AA, McKay R, et al. Definition by specific antisense oligonucleotides of a role for protein kinase Calpha in expression of differentiation markers in normal and neoplastic mouse epidermal keratinocytes. Mol Carcinog 1997;18:44-53
28. Zbytek B, Pikula M, Slominski RM, et al. Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol 2005;152:474-480
29. Takahashi K, Nakanishi S, Imamura S. Direct effects of cutaneous neuropeptides on adenylyl cyclase activity and proliferation in a keratinocyte cell line: stimulation of cyclic AMP formation by CGRP and VIP/PHM, and inhibition by NPY through G protein-coupled receptors. J Invest Dermatol 1993;101:646-651
30. Wollina U, Huschenbeck J, Knoll B, et al. Vasoactive intestinal peptide supports induced migration of human keratinocytes and their colonization of an artificial polyurethane matrix. Regul Pept 1997;70:29-36
31. Gabrilovac J, Cupic B, Breljak D, et al. Expression of CD13/aminopeptidase N and CD10/neutral endopeptidase on cultured human keratinocytes. Immunol Lett 2004;91:39-47
32. Spenny M, Muangman P, Sullivan SR, et al. Neutral endopeptidase inhibition in diabetic wound repair. Wound Repair Regen 2002;10:295-301
33. Donnarumma G, Paoletti I, Buommino E, et al. alpha-MSH reduces the internalization of Staphylococcus aureus and down-regulates HSP 70, integrins and cytokine expression in human keratinocyte cell lines. Exp Dermatol 2004;13:748-754
34. Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002;28:97-103
35. Redondo P, Garcia-Foncillas J, Okroujnov I, Bandres E. alpha-MSH regulates interleukin-10 expression by human keratinocytes. Arch Dermatol Res 1998;290:425-428
36. Park H, Kim HJ, Lee JH, et al. Corticotropin-releasing hormone (CRH) downregulates interleukin-18 expression in human HaCaT keratinocytes by activation of p38 mitogen-activated protein kinase (MAPK) pathway. J Invest Dermatol 2005;124:751-755
37. Song I, Bunnett NW, Olerud JE, et al. Substance P induction of murine keratinocyte PAM 212 interleukin 1 production is mediated by the neurokinin 2 receptor (NK-2R). Exp Dermatol 2000;9:42-52
38. Liu J, Zhao YZ, Peng C, et al. Effect of cetirizine hydrochloride on the expression of substance P receptor and cytokines production in human epidermal keratinocytes and dermal fibroblasts. Yao Xue Xue Bao 2008;43:383-387
39. Dallos A, Kiss M, Polyanka H, et al. Effects of the neuropeptides substance P, calcitonin gene-related peptide, vasoactive intestinal polypeptide and galanin on the production of nerve growth factor and inflammatory cytokines in cultured human keratinocytes. Neuropeptides 2006;40:251-263
40. Yaping E, Golden SC, Shalita AR, et al. Neuropeptide (calcitonin gene-related peptide) induction of nitric oxide in human keratinocytes in vitro. J Invest Dermatol 2006;126:1994-2001
41. Park H, Kim HJ, Lee JY, et al. Adrenocorticotropin hormone stimulates interleukin-18 expression in human HaCaT keratinocytes. J Invest Dermatol 2007;127:1210-1216
42. Goldsby R, Kindt TJ, Osborne BA. Kuby Immunology. 5th edition. W.H. Freeman & Co, New York; 2003;4-43
43. Dunzendorfer S, Kaser A, Meierhofer C, et al. Cutting edge: peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells. J Immunol 2001;166:2167-2172
44. Marriott I, Bost KL. Expression of authentic substance P receptors in murine and human dendritic cells. J Neuroimmunol 2001;114:131-141
45. Mathers A, Tckacheva OA, Janelsins BM, et al. In vivo signaling through the neurokinin 1 receptor favors transgene expression by Langerhans cells and promotes the generation of Th1-and Tc1-biased immune responses. J Immunol 2007;178:7006-7017
46. Joachim R, Handjiski B, Blois SM, et al. Stress-induced neurogenic inflammation in murine skin skews dendritic cells towards maturation and migration: key role of intercellular adhesion molecule-1/leukocyte function-associated antigen interactions. Am J Pathol 2008;173:1379-1388
47. Tori H, Tamaki K, Granstein RD. The effect of neuropeptides/hormones on Langerhans cells. J Dermatol Sci 1998;20:21-28
48. Carucci J, Ignatius R, Wei Y, et al. Calcitonin gene-related peptide decreases expression of HLA-DR and CD86 by human dendritic cells and dampens dendritic cell-driven T cell-proliferative responses via the type I calcitonin gene-related peptide receptor. J Immunol 2000;164:3494-3499
49. Harzenetter M, Novotny AR, Gais P, et al. Negative regulation of TLR responses by the neuropeptide CGRP is mediated by the transcriptional repressor ICER. J Immunol 2007;179:607-615
50. Ding W, Wagner JA, Granstein RD. CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activation. J Invest Dermatol 2007;127(10):2357-2367
51. Ding W, Stohl LL, Wagner JA, Granstein RD. Calcitonin gene-related peptide biases Langerhans cells toward Th2-type immunity. J Immunol 2008;181:6020-6026
52. Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit interleukin-12 transcription by regulating nuclear factor kappaB and Ets activation. J Biol Chem 1999;274:31930-31940
53. Lam C, Perretti M, Getting SJ. Melanocortin receptor signaling in RAW264.7 macrophage cell line. Peptides 2006;27:404-412
54. Lipton J, Zhao H, Ichiyama T, et al. Mechanisms of antiinflammatory action of alpha-MSH peptides. In vivo and in vitro evidence. Ann NY Acad Sci 1999;20:173-182
55. Lotti T, Bianchi B, Ghersetich I, et al. Can the brain inhibit inflammation generated in the skin? The lesson of alpha-melanocyte-stimulating hormone. Int J Dermatol 2002;41:311-318
56. Bellocq A, Doublier S, Suberville S, et al. Somatostatin increases glucocorticoid binding and signaling in macrophages by blocking the calpain-specific cleavage of Hsp 90. J Biol Chem 1999;274:36891-36896
57. Sun J, Ramnath RD, Tamizhselvi R, Bhatia M. Neurokinin A engages neurokinin-1 receptor to induce NF-kappaB-dependent gene expression in murine macrophages: implications of ERK1/2 and PI 3-kinase/Akt pathways. Am J Physiol Cell Physiol 2008;295:C679-691
58. Sun J, Ramnath RD, Tamizhselvi R, Bhatia M. Role of protein kinase C and phosphoinositide 3-kinase-Akt in substance P-induced proinflammatory pathways in mouse macrophages. FASEB J 2009;23:997-1010
59. Tsatsanis C, Androulidaki A, Alissafi T, et al. Corticotropin-releasing factor and the urocortins induce the expression of TLR4 in macrophages via activation of the transcription factors PU.1 and AP-1. J Immunol 2006;176(3):1869-1877
60. Dimitrijevic M, Vujic V, Beck-Sickinger A, Von Horsten S. Neuropeptide Y and its receptor subtypes specifically modulate rat peritoneal macrophage functions in vitro: counter regulation through Y1 and Y2/ 5 receptors. Regul Pept 2005;124:163-172
61. Chedeville A, Mirossay L, Chastre E, et al. Interaction of VIP, PACAP and related peptides in normal and leukemic human monocytes and macrophages. FEBS Lett 1993;319:171-176
62. Delgado M, Garrido E, de La Fuente M, Gomariz RP. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) stimulates rat peritoneal macrophage functions. Peptides 1996;17(7):1097-1105
63. Church M, el-Lati S, Caulfield JP. Neuropeptide induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991;9:310-318
64. Lowman M, Benyon RC, Church MK. Characterization of neuropeptide-induced histamine release from human dispersed skin mast cells. Br J Pharmacol 1988;95:121-130
65. Khare V, Albino AP, Reed JA. The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions. J Cutan Pathol 1998;25:2-10
66. Okabe T, Hide M, Hiragun T, et al. Bone marrow derived mast cell acquire responsiveness to substance P with Ca2+ signals and release of leukotriene B4 via mitogen-activated protein kinase. J Neuroimmunol 2006;181:1-12
67. Ansel JC, Song I, Quinlan KL, et al. Interactions of the skin and nervous system. J Invest Dermatol 1997;2:23-26
68. Azzolina A, Guarneri P, Lampiasi N. Involvement of p38 and JNK MAPKs pathways in Substance P-induced production of TNF-alpha by peritoneal mast cells. Cytokine 2002;18:72-80
69. Gibbs B, Wierecky J, Welker P, et al. Human skin mast cells rapidly release preformed and newly generated TNF-alpha and IL-8 following stimulation with anti-IgE and other secretagogues. Exp Dermatol 2001;10:312-320
70. Chien C, Yu HJ, Lin TB, et al. Substance P via NK1 receptor facilitates hyperactive bladder afferent signaling via action of ROS. Am J Physiol Renal Physiol 2003;284:F840-851
71. Matsuda H, Kawakita K, Kiso Y, et al. Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunol 1989;142:927-931
72. Matsushima M, Kitaichi K, Tatsumi Y, et al. The expression of mRNA for calcitonin receptor-like receptor/receptor-activity modifying proteins in rat peritoneal mast cells. Eur J Pharmacol 2003;464:111-114
73. Walls A, Brain SD, Desai A, et al. Human mast cell tryptase attenuates the vasodilator activity of calcitonin gene-related peptide. J Biochem Pharmacol 1992;43:1243-1248
74. Seebeck J, Kruse ML, Schmidt-Choudhury A, et al. Pituitary adenylate cyclase activating polypeptide induces multiple signaling pathways in rat peritoneal mast cells. Eur J Pharmacol 1998;352:343-350
75. Artuc M, Bohm M, Grutzkau A, et al. Human mast cells in the neurohormonal network: expression of POMC, detection of precursor proteases, and evidence for IgE-dependent secretion of alpha-MSH. J Invest Dermatol 2006;126:1934-1936
76. Cao J, Cetrulo CL, Theoharides TC. Corticotropin-releasing hormone induces vascular endothelial growth factor release from human mast cells via the cAMP/protein kinase A/p38 mitogen-activated protein kinase pathway. Mol Pharmacol 2006;69:998-1006
77. Theoharides T, Donelan JM, Papadopoulou N, et al. Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci 2004;25:563-568
78. Singh L, Boucher W, Pang X, et al. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of corticotropin-releasing hormone receptors. J Pharmacol Exp Ther 1999;288:1349-1356
79. Hart P, Townley SL, Grimbaldeston MA, et al. Mast cells, neuropeptides, histamine, and prostaglandins in UV-induced systemic immunosuppression. Methods 2002;28:79-89
80. Apfel SC. Neurotrophic factors and diabetic peripheral neuropathy. Eur Neurol 1999;41:27-34
81. Dinh T, Veves A. International Textbook of Diabetes Mellitus. 3rd edition. John Wiley & Sons, Chichester; 2004;1315-1332
82. Dellon AL. Neurosurgical prevention of ulceration and amputation by decompression of lower etremity peripheral nerves in diabetic neuropathy: update 2006. Acta Neurochur Suppl 2007;100:149-151
83. Gibran N, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002;108:122-128
84. Engin C, Demirkan F, Ayhan S, et al. Delayed effect of denervation on wound contraction in rat skin. Plast Reconstr Surg 1996;98:1063-1067
85. Peters E, Kuhlmei A, Tobin DJ, et al. Stress exposure modulates peptidergic innervation and degranulates mast cells in murine skin. Brain Behav Immun 2005;19:252-262
86. Muangman P, Tamura RN, Muffley LA, et al. Substance P enhances wound closure in nitric oxide synthase knockout mice. J Surg Res 2009;153:201-209
87. Delgado M, Leceta J, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit the production of inflammatory mediators by activated microglia. J Leukoc Biol 2003;73:155-164
88. Antezana M, Sullivan SR, Usui M, et al. Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers. J Invest Dermatol 2002;119:1400-1404
89. Lindberger M, Schroder HD, Schultzberg M, et al. Nerve fibre studies in skin biopsies in peripheral neuropathies. I. Immunohistochemical analysis of neuropeptides in diabetes mellitus. J Neurol Sci 1989;93:289-296
90. Gibran N, Jang YC, Isik FF, et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J Surg Res 2002;108:122-128
91. Toda M, Suzuki T, Hosono K, et al. Roles of calcitonin gene-related peptide in facilitation of wound healing and angiogenesis. Biomed Pharmacother 2008;62:352-359
92. Ambalavanar R, Dessem D, Moutanni A, et al. Muscle inflammation induces a rapid increase in calcitonin gene-related peptide (CGRP) mRNA that temporally relates to CGRP immunoreactivity and nociceptive behavior. Neuroscience 2006;143:875-884
93. Sheykhzade M, Dalsgaard GT, Johansen T, Nyborg NC. The effect of long-term streptozotocin-induced diabetes on contractile and relaxation responses of coronary arteries: selective attenuation of CGRP-induced relaxations. Br J Pharmacol 2000;129:1212-1218
94. Wallengren J, Badendick K, Sundler F, et al. Innervation of the skin of the forearm in diabetic patients: relation to nerve function. Acta Derm Venereol 1995;7:37-42
95. Ekstrand A, Cao R, Bjorndahl M, et al. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA 2003;100:6033-6038
96. Gohshi A, Honda K, Tominaga K, et al. Changes in adrenocorticotropic hormone (ACTH) release from the cultured anterior pituitary cells of streptozotocin-induced diabetic rats. Biol Pharm Bull 1998;21:795-799
97. Chan O, Inouye K, Vranic M, Matthews SG. Hyperactivation of the hypothalamo-pituitary-adrenocortical axis in streptozotocin-diabetes is associated with reduced stress responsiveness and decreased pituitary and adrenal sensitivity. Endocrinology 2002;143:1761-1768
98. Detillion C, Craft TK, Glasper ER, et al. Social facilitation of wound healing. Psychoneuroendocrinology 2004;29:1004-1011
99. Kalin N, Shelton SE, Engeland CG, et al. Stress decreases, while central nucleus amygdala lesions increase, IL-8 and MIP-1alpha gene expression during tissue healing in non-human primates. Brain Behav Immun 2006;20:564-568
100. Fernstrom M, Mirski MA, Carraway RE, Leeman SE. Immunoreactive neurotensin levels in pancreas: elevation in diabetic rats and mice. Metabolism 1981;30:853-855